Home  /  GP Services  /  Cancer Screening

Cancer screening in Singapore

Cancer Screening in Singapore

Cancer screening looks for cancer — or the early changes that lead to it — before you have any symptoms. Alongside Singapore's national programmes, we offer multi-cancer early detection: a single blood draw that screens for signals from up to 50 cancers, including many with no screening programme at all.

3National programmes
Up to 50Cancers, one blood draw
Screen for LifeSubsidised
AccessibleClinics across Singapore
Doctor explaining cancer screening options to a patient
Why it matters

What is cancer screening?

Cancer screening is testing for cancer in people who feel well and have no symptoms. Because early-stage cancers are often silent, screening is the best way to find them early — or to spot precancerous changes that can be treated before cancer ever develops.

In Singapore, three cancers are recommended for regular population screening — breast, cervical and colorectal — with other checks added based on your personal risk.

Why go for regular cancer screening

  • Find cancer early, when treatment works best
  • Detect precancerous changes before they turn into cancer
  • Most cancers have no symptoms in their early stages
  • Most patients have no family history — everyone benefits
Recommended for everyone

National cancer screening programmes

Singapore has three population-wide cancer screening programmes, subsidised under Screen for Life. These remain the foundation of your cancer screening.

Breast cancer

TestMammogram
Who it's forWomen 50+ (40–49 after discussion)
How oftenEvery 2 years (yearly at 40–49)
Subsidised under Screen for Life; often free for Healthier SG enrollees

Cervical cancer

TestPap test / HPV test
Who it's forWomen 25–69 who've ever had sex
How oftenPap every 3 yrs (25–29); HPV every 5 yrs (30–69)
Subsidised under Screen for Life; often free for Healthier SG enrollees

Colorectal cancer

TestFIT (stool) · colonoscopy
Who it's forAdults 50+ (earlier if higher risk)
How oftenFIT yearly; colonoscopy as advised
Subsidised under Screen for Life; often free for Healthier SG enrollees
The problem

The gap in traditional cancer screening

Established screening has saved millions of lives. But it has a structural limit: it screens one cancer at a time, and only where a test exists.

BreastMammogram — national programme
CervicalPap / HPV test — national programme
ColorectalFIT / colonoscopy — national programme
PancreaticNo screening programme
OvarianNo screening programme
LiverNo general programme
OesophagealNo screening programme
StomachNo general programme
Many othersNo screening programme

Cancers without a screening programme are often found late, once symptoms appear — which is exactly when they are hardest to treat. This is the gap that multi-cancer early detection sets out to close.

Multi-cancer early detection

Lucence: up to 50 cancers, one blood draw

For advanced cancer screening we use Lucence, a Singapore-founded precision oncology laboratory. Its screening test, LucenceINSIGHT, is a multi-cancer early detection (MCED) liquid biopsy.

Tumours shed fragments of their DNA into the bloodstream. LucenceINSIGHT reads that circulating tumour DNA (ctDNA) from a single blood draw, looking for signals from up to 50 cancers — and, if a signal is found, indicating the likely tissue of origin to guide investigation.

  • Screens for cancers with no screening programme at all
  • Genetic-based — far more specific than protein tumour markers
  • No fasting, no bowel prep, no radiation, no biopsy
99%Specificity — low false-positive rate
~81%Sensitivity
Up to 50Cancers screened
~88%Tissue-of-origin accuracy
Figures reported from Lucence clinical validation studies for LucenceINSIGHT. LucenceINSIGHT is a prescription screening test and does not diagnose cancer.
Compare

Lucence vs traditional cancer screening

Where multi-cancer blood testing is genuinely better — and where traditional screening remains irreplaceable.

 Traditional screeningLucence (LucenceINSIGHT)
Cancers coveredOne cancer per test — breast, cervical, colorectalSignals from up to 50 cancers in one test
Cancers with no programmeNot covered — pancreatic, ovarian, oesophageal and othersCovered — this is the core advantage
What it measuresImages, cells or blood in stoolCirculating tumour DNA — a direct genetic signal
PreparationBowel prep, radiation, or an intimate examinationA single blood draw — no prep, no radiation
Diagnostic?Mammogram and colonoscopy can lead directly to biopsyNo — a positive result needs confirmatory tests
Evidence baseDecades of data; proven to reduce cancer deathsClinically validated; long-term mortality data still emerging
CostSubsidised under Screen for LifeSelf-funded

Swipe the table sideways to see all columns →

Where Lucence is better

  • Covers cancers that traditional screening structurally cannot
  • One blood draw instead of several separate tests
  • No fasting, bowel prep, radiation or discomfort
  • Reads tumour DNA directly — not proteins that fluctuate
  • Can indicate where in the body the signal came from
  • Removes a common reason people skip screening: dread

What it cannot do

  • It does not replace your mammogram, Pap test or colonoscopy
  • It is a screening test, not a diagnosis — positives need confirming
  • Some early cancers shed little DNA and may be missed
  • A negative result is not a guarantee you are cancer-free
  • Long-term evidence that it reduces cancer deaths is still being gathered
  • Self-funded, and prescribed only after a doctor's assessment

The honest position: Lucence complements traditional cancer screening rather than replacing it. Used together, they cover far more ground than either can alone — and our doctors will make sure your national screening stays on schedule.

Is it for you?

Who should consider Lucence multi-cancer screening?

LucenceINSIGHT is a prescription test. Our doctors will assess whether it is appropriate for you.

  • Adults aged around 40–50 and above
  • Those with a strong family history of cancer
  • People with a known genetic predisposition
  • Long-term smokers, or those with significant lifestyle risk factors
  • Anyone wanting coverage beyond the three national programmes
  • Those already up to date with their recommended screening
Cancer screening at a glance

Which cancer screening, and when

A quick guide to recommended cancer screening in Singapore. Your doctor will tailor this to you.

CancerScreening testWho it's forHow often
BreastMammogramWomen 50+ (40–49 after a discussion of risks & benefits)Every 2 years; yearly for ages 40–49
CervicalPap test / HPV testWomen 25–69 who have ever been sexually activePap every 3 yrs (25–29); HPV every 5 yrs (30–69)
ColorectalFIT (stool) or colonoscopyAdults 50 and above (earlier if higher risk)FIT yearly; colonoscopy as advised
ProstatePSA blood testMen 50+, or earlier with a family historyAs advised by your doctor
LiverAFP blood test + ultrasoundHepatitis B/C carriers, or those with cirrhosisEvery 6–12 months (higher risk)
LungLow-dose CT scanLong-term or heavy smokersAs advised (risk-based)
Up to 50 cancersLucence — multi-cancer blood testAdults ~40–50+, or higher risk, alongside standard screeningAs advised by your doctor

Swipe the table sideways to see all columns →

Based on your risk

Other cancer screening you may consider

Beyond the national programmes, these checks are recommended based on your personal risk factors.

Prostate (PSA)

A blood test for men, usually from age 50 — or earlier with a family history of prostate cancer.

Liver

An AFP blood test with ultrasound, for hepatitis B or C carriers and those with liver cirrhosis.

Lung

Low-dose CT screening, considered for long-term or heavy smokers based on your risk.

Tumour markers

Protein markers (CEA, CA 125, AFP) — a limited adjunct, and far less specific than reading tumour DNA.

More affordable

Cancer screening subsidies

National schemes help make recommended cancer screening affordable — or free.

Screen for Life

Nationally subsidised breast, cervical and colorectal cancer screening for eligible Singaporeans and PRs.

Healthier SG

For enrolled Singapore Citizens, the mammogram, FIT and Pap/HPV tests are fully subsidised when done or referred by your enrolled GP.

CHAS & Pioneer / Merdeka

Additional subsidies at CHAS clinics for eligible cardholders on selected screening tests.

Lucence

Multi-cancer blood testing is self-funded. Contact us for current pricing.

What to expect

Your cancer screening, step by step

Simple, supportive and clearly explained — including what happens if something is found.

1. Risk review

We assess your age, sex, lifestyle and family history to recommend the right tests.

2. Screening

Your tests — from a FIT kit or Pap smear to a mammogram or a Lucence blood draw.

3. Results & review

A doctor explains your results and what they mean for you.

4. Follow-up

If a signal is found, we arrange confirmatory tests and a specialist referral.

Good to know

Cancer screening & Lucence FAQs

Which cancer screenings do I need in Singapore?
Three cancers are recommended for regular population screening: breast (mammogram), cervical (Pap or HPV test) and colorectal (FIT stool test). Depending on your age, sex, family history and lifestyle, your doctor may also suggest prostate (PSA), liver or lung screening — and, for broader coverage, a Lucence multi-cancer blood test.
What is Lucence?
Lucence is a Singapore-founded precision oncology laboratory, headquartered in Singapore with operations in the United States and Hong Kong. It develops liquid biopsy tests that read fragments of tumour DNA circulating in the blood. Its screening test, LucenceINSIGHT, is used for multi-cancer early detection.
What is LucenceINSIGHT?
LucenceINSIGHT is a multi-cancer early detection (MCED) test. From a single blood draw, it screens for signals from up to 50 cancers by analysing circulating tumour DNA (ctDNA), and can indicate the likely tissue of origin if a signal is found.
How is the Lucence test better than traditional cancer screening?
It isn't a replacement — it's a complement, and it's better at specific things. Traditional screening covers only a handful of cancers and requires a separate test for each. Lucence screens for up to 50 cancers from one blood draw, including many that have no screening programme at all — pancreatic, ovarian, liver, oesophageal and stomach cancers among them. It needs no bowel prep, no radiation and no discomfort. What it cannot do is replace a mammogram, Pap test or colonoscopy, which remain essential.
How accurate is the Lucence cancer screening test?
In clinical validation studies, LucenceINSIGHT reported around 99% specificity — meaning a low false-positive rate — with about 81% sensitivity, and it can indicate the likely tissue of origin with roughly 88% accuracy. Because it is genetic-based rather than protein-based, it is more accurate than traditional tumour-marker blood tests.
Does the Lucence test replace my mammogram, Pap smear or colonoscopy?
No. It complements them. No multi-cancer blood test is approved to replace guideline-recommended screening, and relying on one alone risks false reassurance. Our doctors will make sure your standard screening stays on schedule alongside it.
Who should consider a multi-cancer blood test?
It is generally considered for adults aged around 40 or 50 and above, and for those at higher risk — a strong family history, known genetic predisposition, or significant lifestyle risk factors. It is a prescription test, so our doctors will assess whether it is appropriate for you.
What happens if the Lucence test finds a cancer signal?
A positive result is not a diagnosis. It means a signal has been detected, and the test may suggest the likely tissue of origin to guide investigation. Your doctor will arrange confirmatory tests — imaging, endoscopy or biopsy as appropriate — and support you through that process.
Can a blood test miss a cancer?
Yes. Some cancers shed little DNA into the bloodstream, particularly at very early stages, so a negative result does not guarantee you are cancer-free. This is precisely why the test complements, rather than substitutes for, your recommended screening.
Are tumour marker blood tests the same thing?
No. Traditional tumour markers such as CEA and CA 125 measure proteins, and are prone to both false positives and missed cancers. Multi-cancer tests such as LucenceINSIGHT read tumour DNA directly, which is a fundamentally more specific signal.
At what age should I start cancer screening?
In Singapore, cervical screening starts at 25, breast screening (mammogram) at 40–50, and colorectal screening at 50. Those with a family history or higher risk may need to start earlier — we'll advise you.
Is cancer screening subsidised or free?
Breast, cervical and colorectal screening are subsidised under Screen for Life, and are often fully subsidised for Singapore Citizens enrolled in Healthier SG when done or referred by their enrolled GP. CHAS and Pioneer/Merdeka subsidies may also apply. Multi-cancer blood tests such as LucenceINSIGHT are self-funded.
Do I need cancer screening if I feel well or have no family history?
Yes. Early-stage cancers often cause no symptoms at all, and most people who develop these cancers have no family history. Regular screening is how they are caught early, when they are most treatable.
What's the difference between men's and women's cancer screening?
Women's screening focuses on breast and cervical cancer (plus colorectal), while men's focuses on colorectal and, where appropriate, prostate (PSA). Colorectal screening is recommended for everyone from age 50.
Related

You may also be interested in

Book your cancer screening today

Early detection saves lives. Talk to our doctors about your national screening, and whether Lucence multi-cancer detection is right for you.

Book a cancer screening

Sources

The requirements and recommendations on this page are drawn from official Singapore government sources:

This page is general information, not medical advice, and requirements can change. Always confirm the current position with the relevant Singapore government agency, or speak to our doctors about your own circumstances.